Products

Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharmaceuticals products? Contact one of our trusted professionals today.

Call (800) 521-5340
info@risingpharma.com

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharmaceuticals, Inc. or its affiliates.

Indicated to treat and prevent overactive parathyroid glands in patients with chronic kidney disease who are on dialysis.

Paricalcitol Soft Gel Capsules Paricalcitol Soft Gel Capsules

Paricalcitol Soft Gel Capsules

Compare to: Zemplar® Capsules*
Strength: 1mcg | 2mcg
* Zemplar® is a registered trademark of AbbVie Inc.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

1.1 Chronic Kidney Disease Stages 3 and 4

Paricalictol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4.

 

1.2 Chronic Kidney Disease Stage 5

Paricalcitol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD).